Pyrovalerone | |
---|---|
Molecular structure via molpic | |
Molecular formula | C16H23NO[1] |
Molecular mass | 245.36 g/mol[1] |
Predicted LogP | 3.8[1] |
Chirality | racemic[2] |
Identifiers [] | |
---|---|
IUPAC name | 1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one[1] |
SMILES | CCCC(C(=O)C1=CC=C(C=C1)C)N2CCCC2[1] |
InChI | InChI=1S/C16H23NO/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14/h7-10,15H,3-6,11-12H2,1-2H3[1] |
InChIKey | SWUVZKWCOBGPTH-UHFFFAOYSA-N[1] |
Dosing |
---|
Pyrovalerone
Pyrovalerone (also known as Pirovalerona, Pyrovaleronum, 4'-Methyl-2-(1-pyrrolidinyl)valerophenone, 1-Pentanone, 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-, J8.659B, Valerophenone, 4'-methyl-2-(1-pyrrolidinyl)-, 1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one, 1-P-tolyl-1-oxo-2-pyrrolidino-n-pentane, 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one or DAA56349) is a stimulant substance of the pyrrolidinophenone class.
Chemistry
Pyrovalerone is typically found in the form of its hydrochloride salt.
Subjective effects
Legal status
- Australia: Pyrovalerone is a S4 substance.
- Brazil: Pyrovalerone is a B1 substance.
- Canada: Pyrovalerone is a Schedule IV substance.
- United States: Pyrovalerone is a Schedule V substance.
- United Kingdom: Pyrovalerone is a Class C substance.
- Germany: Pyrovalerone is a Anlage II substance.